Stocks and Investing
Stocks and Investing
Thu, January 3, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jason Gerberry Downgraded (ABBV) to Hold on, Jan 3rd, 2019
Jason Gerberry of B of A Securities, Downgraded "AbbVie Inc." (ABBV) to Hold on, Jan 3rd, 2019.
Jason has made no other calls on ABBV in the last 4 months.
There are 2 other peers that have a rating on ABBV. Out of the 2 peers that are also analyzing ABBV, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $115 on, Tuesday, November 6th, 2018
- Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $71 on, Monday, November 5th, 2018
Contributing Sources